NextCure
Financing Rounds
- Public
- Exit
Round Led by Symbiosis
Round Led by Symbiosis
NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Through its proprietary FIND-IO™ platform, NextCure studies various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. The company’s initial focus is to develop new treatments for patients who do not respond to current cancer therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.
View Website
Modality
- Biologic
Indication
- Oncology
Development Status
- Phase 2